Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bacterial proteins with thiol groups represent a broad and essential class of therapeutic targets for various antimicrobial agents, including heavy metals, reactive sulfur species, and certain natural products. Thiol groups (-SH), located on cysteine residues, are vital for the catalytic function of numerous enzymes, the structural stability of proteins via disulfide bridges, and the maintenance of cellular redox balance (NIH, 2018). Drugs such as silver ions (e.g., silver nitrate) and organomercurials (e.g., thimerosal) exert their bactericidal effects by binding covalently to these sulfhydryl groups, causing protein denaturation and systemic metabolic failure within the bacterial cell (Goodman & Gilman, 2018). This multi-target approach is highly effective against a wide range of pathogens and significantly reduces the likelihood of resistance development compared to single-target antibiotics. However, the presence of similar thiol groups in human proteins often limits the use of these agents to topical applications or environmental disinfection due to the risk of host toxicity. Understanding the interaction between drugs and the bacterial thiol proteome remains a key area for developing novel redox-based antimicrobial therapies (ResearchGate, 2022).
Covalent modification of cysteine sulfhydryl groups, leading to enzyme inhibition, protein denaturation, and disruption of bacterial metabolism and redox balance.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial proteins with thiol groups.